The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.20
Bid: 63.20
Ask: 65.40
Change: 0.00 (0.00%)
Spread: 2.20 (3.481%)
Open: 64.20
High: 0.00
Low: 0.00
Prev. Close: 64.20
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

29 May 2018 07:48

RNS Number : 4884P
IDOX PLC
29 May 2018
 

 

29 May 2018

Idox plc

 

('Idox' or 'the Group' or 'the Company')

 

Directorate Change

 

David Meaden appointed Chief Executive

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today announces the appointment of David Meaden as its new Chief Executive, subject to completion of the customary regulatory procedures. David will join Idox on 1 June 2018. This is a significant appointment for the Group following the uncertainty over the Group's leadership in the last six months.

 

David enjoyed a 22 year career, including 12 years as Chief Executive, with Northgate Public Services (NPS) a leading supplier of specialist software, information technology and business process outsourcing services to public sector markets. NPS was a part of Northgate Information Solutions (NIS), a FTSE 250 company, of which David was a member of the PLC Board from 2004 through to the sale of NIS to KKR, the US Private Equity firm in December 2007. He then led the business through its successful sale to Cinven in 2014.

 

David has substantial experience of working with the UK Public Sector and during his tenure with Northgate Public Services, grew the business four fold to become a leading provider to Local Government, Police, Healthcare and Central Government agencies, employing around 2,300 staff across 8 UK locations and a development centre in India. David has significant experience of business transformation, software development, outsourcing and M&A successfully integrating nine acquisitions during his time at the helm.

 

He spent his early career in product management and sales at Burroughs and Group Bull and has a degree in Business Studies from the University of Huddersfield.

 

Richard Kellett-Clarke, who has been acting as Chief Executive on an interim basis since December 2017 will hand over responsibilities to David Meaden on 1 June and revert to his previous role as a non-executive director at that time. The Board expresses its thanks to Richard who stepped into the role at very short notice and has played an important part in stabilising the business and leading the various business reviews.

 

A further announcement regrading the appointment will be made in due course, following completion of the customary regulatory procedures.

 

David Meaden said:

"I am delighted to be joining Idox at this very important point in its development. I have known Idox for many years as a leading player in the public sector solutions and services market and am confident that it has both attractive products and talented people. I look forward to starting work in June and continuing the transformation of the business."

 

Laurence Vaughan, Chairman of Idox said:

"We are delighted to have secured such as high calibre leader as David Meaden as Idox's new Chief Executive. His previous experience with the UK Public Sector and software development at Northgate Public Services, where he was until recently Chief Executive, is especially relevant.

 

"David will focus on returning Idox to good growth and better profitability through continued focus on digital transformation and high quality governance solutions for the public sector. With this new leadership in place we can look forward to the future with renewed confidence."

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

 

Enquiries:

 

Idox plc +44 (0) 870 333 7101

Laurence Vaughan, Chairman

Richard Kellett-Clarke, Interim Chief Executive Officer

Jane Mackie, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson

Liz Yong

 

MHP (Financial PR) +44 (0) 20 3128 8100

Reg Hoare / Charlie Barker

 

For more information see www.idoxplc.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGLGDURSDBGIC
Date   Source Headline
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights
27th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSYear End Trading Update
9th Nov 202310:25 amRNSHolding(s) in Company
6th Nov 20233:01 pmRNSHolding(s) in Company
2nd Nov 20232:10 pmRNSHolding(s) in Company
2nd Nov 202310:09 amRNSHolding(s) in Company
1st Nov 202311:48 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAdoption of New LTIP and Grant of Options
4th Oct 20237:00 amRNSExercise of Share Options & Total Voting Rights
25th Sep 202310:06 amRNSHolding(s) in Company
11th Sep 20237:00 amRNSExercise of Share Options & Total Voting Rights
31st Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
21st Aug 20237:00 amRNSAcquisition
4th Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
3rd Aug 20231:49 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSChange of Registered Address
14th Jul 20237:00 amRNSExercise of Share Options & Total Voting Rights
27th Jun 20237:00 amRNSExercise of Share Options & Total Voting Rights
13th Jun 20237:00 amRNSPayment of Earnout and Allotment of Shares
12th Jun 20234:44 pmRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf Year results
18th May 20237:00 amRNSHalf Year 2023 Trading Update
23rd Mar 20232:33 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Trading Update
3rd Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
15th Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
9th Feb 202311:03 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSNotice of Final Results
15th Dec 20227:00 amRNSPayment of Earnout and Allotment of Shares
8th Dec 20221:17 pmRNSHolding(s) in Company
16th Nov 20227:00 amRNSTrading Statement
14th Nov 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.